From a drop of blood to a life‑saving decision within five minutes
One drop of blood is all we need.
Faster answers, faster treatment, faster release.
One technology, many biomarkers
The B2X platform is based on electrochemical impedance spectroscopy (EIS). Targeting multiple biomarkers on a microelectrode array (MEA) with laboratory‑grade sensitivity, without laboratory infrastructure.
Developed for blood biomarkers, the same core platform is designed to work with all liquid biological media: saliva, urine, etc.
Cardiac troponin
Cardiovascular disease is the leading cause of death worldwide.
Cardiac troponin is a specific biomarker for diagnosing acute myocardial infarction, measured millions of times everyday.
The need for point of care is clear: every second of delay in centralized laboratories affects patient well-being.
With a sensitivity of 0.5 ng/L, the B2X platform meets the threshold defined by ESC guidelines(opens in a new tab) for high‑sensitivity troponin assays.
One test, multiple biomarkers, one clinical decision.
| Biomarker | Clinical application |
|---|---|
| cTnI | Acute myocardial infarction (AMI) |
| cTnT | AMI complementary |
| NT‑proBNP / BNP | Heart failure diagnosis & monitoring |
| D‑dimer | Pulmonary embolism & DVT exclusion |
| CRP | Systemic inflammation & sepsis triage |
| CspZ | Lyme disease |
| CK‑MB | AMI marker |
| Myoglobin | Early AMI marker |